Board summary
Key figures
87,733
Registered population
77.5% aged 18–64
8.0%
Aged 65+
ICB 13.5% · England 17.9%
49.5%
Ethnic minority (non-White)
11.9% Asian · England 9.6%
15.1%
In IMD quintile 1
ICB 11.4% · England 21.0%
~19,453
Core20 residents (est.)
see page 3
8,445
Hypertension register
+5.49% in 3 yrs · England +5.60%
1,154
SMI register
21.8% of Lewisham (LAD)'s
980
COPD register
Reviews +6.85% in 3 yrs
Forecast to 2030
9,607
Hypertension patients, 2030
+1,162 on today
64.7%
QRISK ≥20% on statins, 2030
+1.50pp over 3 yrs
2.6%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Under-80 blood pressure control trails England.
Control is 61.2% against 67.8% in England after falling 3.1% over 2023 to 2025 (England +3.2%), which may reflect unverified working-age review gaps.
Psychosis alcohol and SMI physical checks lag.
Psychosis alcohol recording fell 8.1 pp to 72.3% (England +5.4 pp), while SMI BMI (72.8%) and blood pressure (76.3%) checks trail England.
COPD and asthma review rates exceed England.
COPD annual reviews reached 78.8% (+6.8% vs England +2.8%) and asthma reviews 68.1% (England 65.7%), though about 1,200 asthma patients remain unreviewed.
Population, age and ethnicity
Working-age adults form 77.5% of registrations alongside an ethnic minority share of 49.5%
Registered patient lists (87,733 total) show 77.5% aged 18–64, above Lewisham (72.8%), NHS South East London ICB (69.6%) and England (62.7%), with 8.0% aged 65+ (LAD 9.9%, ICB 13.5%, England 17.9%). Local Census estimates, rather than GP registers, record a 49.5% ethnic minority share, including 24.6% Black / African / Caribbean / Black British residents (LAD 26.8%, ICB 19.5%, England 4.2%) and 11.9% Asian / Asian British residents (LAD 9.0%, ICB 9.5%, England 9.6%). Services may need flexible scheduling and culturally tailored communication to engage these large working-age and diverse cohorts.
Age profile
65+: ICB 13.5%, England 17.9%
Ethnicity
Older people · falls rows are Lewisham (LAD) local-authority (LA) data, not PCN
| Measure | Local | London | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Lewisham LA) | 2,119 | 2,045 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 79.6% | 82.7% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 53.5% | 56.9% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Lewisham LA) | 1,231 | 1,069 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Lewisham LA) | 13.1 | 11.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Registered Core20 share is 15.1% but spans 29.7 percentage points across constituent practices
North Lewisham PCN has an average IMD decile of 4.3 (Lewisham 4.1, ICB 5.3, England 5.5). Registered Core20 share is 15.1%, below Lewisham (20.1%), above the ICB (11.4%) and below England (21.0%). Practice deprivation spans 29.7 pp, from 0.0% at Vesta Road Surgery to 29.7% at New Cross Centre (hurley Group). Resident estimates show about 19,500 people in deciles 1 and 2 (14,400 aged 18-64; 3,635 aged 0-17), though resident and registered bases differ. Outreach should focus on practices with high Core20 shares to address sharp intra-PCN inequalities.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
1,154
SMI register
1.26% recorded prevalence
367
Learning disability register
0.40% recorded prevalence
5
Care homes, 237 beds
In the PCN catchment
7.7%
Provide unpaid care
Lewisham (LAD), Census 2021
The PCN records 1,154 severe mental illness patients (1.3% prevalence vs LAD 1.5%, ICB 1.2%, England 1.0%) and 367 learning disability patients (0.4% vs LAD 0.6%, ICB 0.5%, England 0.6%). Five catchment care homes contain 237 beds. The severe mental illness register is above England, so physical-health checks for this cohort could be the key workload to protect.
Severe mental illness: physical health checks
SMI physical health checks trail England: blood pressure checks reached 76.3% (England 83.4%), BMI was 72.8% (England 82.1%), and alcohol recording for psychosis fell 8.1 pp over 2023 to 2025 to 72.3% (England +5.4 pp).
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
8,445
Hypertension register
+5.49%
Register growth, 3 yrs
Lewisham (LAD) +3.77% · England +5.60%
−1.99pp
BP control, under 80
≤140/90 · +4.72pp aged 80+
+1,162
More patients by 2030
Forecast 9,607 (10.25%)
Hypertension case-finding and control
Recorded hypertension prevalence is 9.2% (8,445 patients), below Lewisham (11.5%), the ICB (12.1%), and England (15.2%), with an implied base of 91,694 against 87,733 registered patients. Recent blood pressure checks reached 85.2% (England 90.0%). For patients aged under 80, blood pressure control is 61.2%, below Lewisham (62.9%), the ICB (66.9%), and England (67.8%), after falling 3.1% over 2023 to 2025 (England +3.2%). For patients aged 80 and over, blood pressure control reached 76.9% (England 81.2%), rising 6.5% over 2023 to 2025 (England +2.2%). Overall blood pressure treated to target is 63.3% (England 70.3%). Lower under-80 control may reflect routine review pressures, which board recall could address.
Lipids and statins
Among patients with QRISK ≥ 20%, 61.6% receive lipid-lowering therapy, trailing Lewisham (61.7%), the ICB (62.4%), and England (63.6%), with 2023 to 2025 growth of 2.5% behind England (+6.2%). Patients with diabetes and CVD treated with a statin reached 85.1% (England 84.4%). Primary prevention statin uptake trails national benchmarks.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 55,111 | £2.00 | £1.71 | £1.86 | £110,222 |
| Cardiovascular (all), 2025 | 80,590 | £3.73 | £3.41 | £3.33 | £300,601 |
In 2025, cardiovascular drug cost was £3.73 per item, spending £32,236 more than at England's unit cost across 80,590 items. Lipid-modifying drug cost was £2.00 per item, spending £8,287 more than at England's unit cost across 46,037 items. Higher unit costs may reflect prescribing choices across constituent practices.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+0.49%
Asthma reviews, PCN 3-yr change
+4.44%
Asthma reviews, England
+3.07%
Asthma prevalence, PCN
Annual respiratory reviews exceed national averages: COPD review coverage is 78.8% across 980 registered patients (England 76.4%), and asthma review coverage is 68.1% across 3,840 patients (England 65.7%). However, an estimated scale gap of about 1,200 asthma patients remains without a recorded review in the last 12 months. Concurrently, asthma management prescribing for ages 5-19 is 1,331 items per 1000 population, above the ICB rate of 1,091 but below England's 1,488. A sizeable unreviewed asthma cohort persists alongside elevated youth prescribing relative to the ICB.
Cancer register and children's immunisation
Crude recorded cancer prevalence is 1.9% (England 3.8%). In Q1 2025/26, childhood immunisation coverage was below the 95.0% target: 6-in-1 at 12 months was 88.0% and MMR dose 1 at 24 months was 86.4%. At age 5, MMR dose 2 was 74.1% (10.7 pp below dose 1; 20.9 pp below target) and 4-in-1 booster coverage was 64.6% (below target by 30.4 pp). Coverage declines by school entry.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
54.4%
South East London ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,100
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | South East London ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Prostate | 59.6% | 53.2% | 27% | 1,108 |
| Breast | 81.2% | 85.4% | 27% | 986 |
| Lung | 33.5% | 33.8% | 17% | 792 |
| Bowel | 43.3% | 47.0% | 28% | 679 |
| Skin cancer | 89.2% | 87.8% | 35% | 223 |
In 2022, 54.4% of cancers with a known stage (2,904 of 5,337) in NHS South East London ICB were diagnosed at stage 1 or 2, trailing England (55.3%) with distance to the 75.0% national ambition by 2028 at -20.6 pp. Reaching 75.0% requires about 1,100 extra early-stage diagnoses yearly across the ICB, where early-stage share rose +2.9 pp from 2013 to 2022. Staging data reflects system activity, not PCN performance; known-stage completeness was 60.8% (5,337 of 8,785). North Lewisham PCN cervical screening is 61.7% (England 66.8%). Improving primary care screening uptake is essential to support earlier system diagnosis.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
For Lewisham and Greenwich NHS Trust, distance to the 28-day faster diagnosis standard (75.0%) is 8.7 pp. However, distance to the 62-day referral to treatment standard (85.0%) is -16.0 pp, and distance to the 31-day combined treatment standard (96.0%) is -0.8 pp. Across NHS South East London Integrated Care Board, distance to the 28-day standard is 8.5 pp, distance to the 62-day standard is -15.8 pp, and distance to the 31-day standard is -2.1 pp. These provider and ICB metrics show prompt initial diagnosis alongside treatment delays.
| Pathways within standard (%) | Lewisham and Greenwich | King's College | Guy's and St Thomas' | South East London ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 83.74 | 80.68 | 86.79 | 83.47 | 79.32 |
| 31-day treatment (96%) | 95.24 | 96.68 | 90.36 | 93.85 | 92.50 |
| 62-day referral to treatment (85%) | 68.98 | 70.15 | 61.50 | 69.17 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Lewisham and Greenwich | King's College | Guy's and St Thomas' | England |
|---|---|---|---|---|
| MRI | 2.30 | 21.22 | 22.48 | 21.40 |
| CT | 10.21 | 22.60 | 20.08 | 9.92 |
| Echocardiography | 6.82 | 14.39 | 20.67 | 28.48 |
| Colonoscopy | 19.65 | 41.81 | 7.51 | 30.83 |
| Gastroscopy | 9.42 | 35.98 | 14.70 | 29.02 |
| All 15 DM01 tests | 27.58 | 19.15 | 25.51 | 23.14 |
| Community services activity | Lewisham residents | South East London ICB |
|---|---|---|
| Care contacts | 56,080 | 296,060 |
| Referrals | 7,845 | 45,320 |
| Patients with a contact | 14,220 | 80,720 |
Community services (residents of Lewisham), Jun 2026 (provisional). In the Community Services Dataset (provisional June 2026), adults aged 65 and over accounted for 50% of contacts for Lewisham borough residents (28,020 of 56,080 total contacts). These figures reflect activity across the local authority rather than PCN-level provision, demonstrating substantial community service contact with older residents across the wider borough.
Practice variation and patient experience
Good practice experience spans 33.3 percentage points from 52.2% to 85.4% across practices
In 2025/26, QOF overall achievement ranged from 37.4% at One Care Lewisham to 99.5% at Amersham Vale Training Practice against England's 92.5%. Vaccination and immunisation domain achievement spanned 84.4 pp, from 15.6% at Clifton Rise Family Practice to 100.0% at Amersham Vale Training Practice.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Grove | 120 | 1.8 | 70.4% | 61.7% | 85.4% |
| One Care Lewisham | 18 | — | 71.2% | 30.5% | 84.7% |
| Deptford | 99 | 0.0 | 70.5% | 83.2% | 82.1% |
| Kingfisher | 113 | 24.4 | 60.2% | 85.6% | 81.6% |
| Clifton Rise | 111 | 26.2 | 63.8% | 59.3% | 81.3% |
| Vesta Road Surgery | 77 | 0.0 | 39.8% | 64.5% | 75.5% |
| Deptford Surgery | 138 | 10.4 | 65.6% | 74.8% | 73.6% |
| Amersham Vale | 113 | 20.6 | 54.6% | 69.4% | 70.7% |
| New Cross Centre | 107 | 29.7 | 50.8% | 62.6% | 66.9% |
| The Qrp Surgery | 99 | 16.4 | 32.8% | 69.7% | 52.2% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Fourteen of 25 measures trail England's three-year change, led by mental health checks
Fourteen of 25 compared measures trail England's three-year change. Psychosis alcohol recording fell 8.1 pp to 72.3% (England +5.4 pp), while heart failure reviews fell 3.1% to 80.4% (England +8.7%). Blood pressure control for patients under 80 fell 3.1% (England +3.2%). Conversely, blood pressure control for patients aged 80 and over rose +6.5% (England +2.2%) and COPD reviews rose +6.8% (England +2.8%). Slower progress on cardiovascular and mental health reviews may reflect recall differences, which practice audits could test.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Alcohol record (psychosis)
Heart failure reviews
BP control, under 80
Hypertension treated to target
BMI record (SMI)
Breast screening (53-70)
BP control, 80+
COPD reviews
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Lewisham (LAD) | Asset | PCN | Lewisham (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 5 (237 beds) | n/a | Schools (catchment) | 67 | n/a |
| Children's centres | 4 | 6 | Places of worship | 37 | 106 |
| Libraries | 2 | 6 | Day centres (VCS) | n/a | 1 |
| Carers support groups (VCS) | n/a | 1 | Primary schools (LA maintained) | 14 | 53 |
| Primary academies | 8 | 12 | Special schools | n/a | 3 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Under-80 blood pressure titration recall
Under-80 blood pressure control is 61.2% (Lewisham 62.9%, ICB 66.9%, England 67.8%), falling 3.1% over 2023 to 2025 (England +3.2%) across 8,445 hypertension patients. For discussion: run a structured recall and pharmacist-led medication titration clinic for registered under-80 hypertensive patients above target. Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Option 2
Combined SMI physical health recall
Across 1,154 SMI patients (1.3% prevalence; 21.8% of Lewisham's register), BP checks are 76.3% (England 83.4%), BMI is 72.8% (England 82.1%), and alcohol recording fell 8.1 pp to 72.3% (England 81.8%). Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Option 3
Structured annual asthma review recall
Asthma review coverage is 68.1% of 3,840 registered patients (Lewisham 63.0%, ICB 65.4%, England 65.7%), with +0.5% three-year change trailing England's +4.4% and an estimated scale gap of 1,225 patients (about 1,200). For discussion: align annual asthma recall with repeat inhaler prescribing reviews and offer after-school or flexible clinic slots. Low cost, quick to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Culturally tailored access review (p2) | Black / African / Caribbean / Black British | Neighbourhood health framework · Core20PLUS5 approach | PCN |
| Targeted Core20 outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| Systematic SMI physical health recall (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Working age blood pressure recall (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school booster outreach and recall (p6) | 4-in-1 pre-school booster (DTaP/IPV) coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall outreach (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Practice access and triage review (p9) | GPPS good overall experience of the practice | 10YHP, hospital to community | Practice |
| Option 1 · Under-80 blood pressure titration recall (p12) | Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Option 2 · Combined SMI physical health recall (p12) | Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Option 3 · Structured annual asthma review recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 Population | Core20PLUS5 respiratory | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | Local authority | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
